Home
Technology
The platform
Artificial Intelligence
BioClick
Nobel Prize heritage
Biosolution phases
Scientific papers
Patents
Pipeline
Pipeline overview
NCT: Over-the-Counter
NCT: Pharma
Cannabinoids
Santalene
Become a partner
Investors
Stock information
News
Email signup
Investor Relation Contacts
Governance
SEC Filings
Video
About
Leadership team
History
Jobs
Contact
News
Latest news
Media coverage
Investor news
Home
investors
NCT presentation by Damien Perriman, CCO
<p>Your web browser does not support iframes, which means that the video cannot play.</p>
investors
NCT presentation by Damien Perriman, CCO
532 views
April 03, 2026
Share
Embed
Download
Link to share
Embed this video
Download this video
Standard
(26MB)
HD
(48MB)
Related videos
investors
EXOZ Investor Update - Q4+2025 (March 31. 2026)
April 01, 2026 · 1,480 views
investors
Invizyne presented by Michael Heltzen & Tyler Korman
July 01, 2024 · 994 views
investors
Investor Presentation by Chris Marlett (May 2026)
May 11, 2026 · 725 views
investors
Invizyne IPO comments by CEO Michael Heltzen
November 11, 2024 · 411 views
investors
Interview: Cayman Chemical validates eXoZymes' technology and scalability
March 18, 2026 · 402 views
investors
Commercializing Invizyne’s cell-free platform - fireside chat
July 30, 2024 · 402 views
